Xbrane Biopharma (Sweden) Price History

XBRANE Stock  SEK 0.18  0.01  5.26%   
If you're considering investing in Xbrane Stock, it is important to understand the factors that can impact its price. As of today, the current price of Xbrane Biopharma stands at 0.18, as last reported on the 27th of November, with the highest price reaching 0.18 and the lowest price hitting 0.18 during the day. Xbrane Biopharma appears to be out of control, given 3 months investment horizon. Xbrane Biopharma shows Sharpe Ratio of 0.0588, which attests that the company had a 0.0588% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Xbrane Biopharma, which you can use to evaluate the volatility of the company. Please utilize Xbrane Biopharma's Downside Deviation of 6.66, mean deviation of 4.77, and Market Risk Adjusted Performance of (0.45) to validate if our risk estimates are consistent with your expectations.
  
Xbrane Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0588

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsXBRANE
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 6.56
  actual daily
58
58% of assets are less volatile

Expected Return

 0.39
  actual daily
7
93% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Xbrane Biopharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Xbrane Biopharma by adding it to a well-diversified portfolio.

Xbrane Biopharma Stock Price History Chart

There are several ways to analyze Xbrane Stock price data. The simplest method is using a basic Xbrane candlestick price chart, which shows Xbrane Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 30, 20240.24
Lowest PriceSeptember 6, 20240.13

Xbrane Biopharma November 27, 2024 Stock Price Synopsis

Various analyses of Xbrane Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Xbrane Stock. It can be used to describe the percentage change in the price of Xbrane Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Xbrane Stock.
Xbrane Biopharma Price Rate Of Daily Change 0.95 
Xbrane Biopharma Price Action Indicator(0.01)

Xbrane Biopharma November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Xbrane Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Xbrane Biopharma intraday prices and daily technical indicators to check the level of noise trading in Xbrane Stock and then apply it to test your longer-term investment strategies against Xbrane.

Xbrane Stock Price History Data

The price series of Xbrane Biopharma for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 0.11 with a coefficient of variation of 15.52. The daily prices for the period are distributed with arithmetic mean of 0.18. The median price for the last 90 days is 0.19.
OpenHighLowCloseVolume
11/27/2024
 0.18  0.18  0.18  0.18 
11/26/2024 0.18  0.18  0.18  0.18  4,826,469 
11/25/2024 0.20  0.20  0.18  0.19  8,094,508 
11/22/2024 0.20  0.20  0.19  0.19  6,489,318 
11/21/2024 0.19  0.20  0.19  0.20  8,501,175 
11/20/2024 0.22  0.22  0.20  0.20  15,539,625 
11/19/2024 0.20  0.29  0.19  0.21  86,739,516 
11/18/2024 0.21  0.21  0.19  0.20  3,017,809 
11/15/2024 0.19  0.21  0.19  0.20  5,718,975 
11/14/2024 0.20  0.21  0.19  0.19  3,279,180 
11/13/2024 0.20  0.21  0.19  0.20  5,205,356 
11/12/2024 0.20  0.21  0.20  0.20  3,256,875 
11/11/2024 0.20  0.21  0.20  0.21  4,035,771 
11/08/2024 0.21  0.22  0.20  0.20  3,114,893 
11/07/2024 0.21  0.21  0.20  0.21  3,798,819 
11/06/2024 0.22  0.22  0.20  0.21  8,004,311 
11/05/2024 0.22  0.23  0.22  0.22  5,387,026 
11/04/2024 0.23  0.23  0.21  0.22  6,129,597 
11/01/2024 0.23  0.24  0.22  0.23  2,939,094 
10/31/2024 0.24  0.24  0.23  0.23  3,421,213 
10/30/2024 0.23  0.24  0.22  0.24  7,155,673 
10/29/2024 0.23  0.25  0.22  0.23  13,809,108 
10/28/2024 0.21  0.24  0.21  0.23  23,862,941 
10/25/2024 0.21  0.22  0.21  0.21  7,513,535 
10/24/2024 0.20  0.22  0.20  0.21  10,575,233 
10/23/2024 0.21  0.21  0.20  0.20  4,450,627 
10/22/2024 0.22  0.23  0.20  0.20  11,522,256 
10/21/2024 0.23  0.26  0.21  0.22  54,256,033 
10/18/2024 0.17  0.18  0.17  0.18  4,424,282 
10/17/2024 0.18  0.18  0.17  0.17  3,608,288 
10/16/2024 0.18  0.18  0.17  0.18  3,700,956 
10/15/2024 0.17  0.19  0.17  0.18  3,787,037 
10/14/2024 0.19  0.19  0.17  0.17  10,631,191 
10/11/2024 0.21  0.21  0.19  0.19  3,747,328 
10/10/2024 0.21  0.22  0.20  0.21  4,721,684 
10/09/2024 0.19  0.22  0.19  0.21  10,698,617 
10/08/2024 0.19  0.20  0.18  0.19  5,675,938 
10/07/2024 0.19  0.19  0.18  0.19  4,393,488 
10/04/2024 0.18  0.18  0.18  0.18  2,335,659 
10/03/2024 0.19  0.19  0.18  0.18  3,974,737 
10/02/2024 0.19  0.19  0.18  0.19  4,568,141 
10/01/2024 0.20  0.20  0.18  0.18  4,680,327 
09/30/2024 0.19  0.20  0.18  0.20  9,082,755 
09/27/2024 0.18  0.24  0.18  0.19  47,904,526 
09/26/2024 0.18  0.18  0.17  0.18  4,803,572 
09/25/2024 0.16  0.19  0.16  0.18  20,121,422 
09/24/2024 0.16  0.16  0.15  0.16  1,663,829 
09/23/2024 0.16  0.16  0.15  0.16  1,810,333 
09/20/2024 0.17  0.17  0.16  0.16  7,460,912 
09/19/2024 0.17  0.17  0.16  0.17  9,463,957 
09/18/2024 0.19  0.19  0.16  0.17  17,867,959 
09/17/2024 0.17  0.19  0.16  0.18  13,895,759 
09/16/2024 0.14  0.17  0.14  0.16  18,111,225 
09/13/2024 0.15  0.16  0.14  0.14  6,604,007 
09/12/2024 0.13  0.17  0.13  0.15  41,878,143 
09/11/2024 0.13  0.13  0.13  0.13  4,944,249 
09/10/2024 0.13  0.13  0.13  0.13  7,750,752 
09/09/2024 0.13  0.14  0.13  0.13  4,500,919 
09/06/2024 0.14  0.14  0.13  0.13  4,945,785 
09/05/2024 0.14  0.14  0.13  0.14  5,868,880 
09/04/2024 0.13  0.14  0.13  0.14  4,773,251 

About Xbrane Biopharma Stock history

Xbrane Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Xbrane is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Xbrane Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Xbrane Biopharma stock prices may prove useful in developing a viable investing in Xbrane Biopharma
Xbrane Biopharma AB , a biopharmaceutical company, develops and manufactures biosimilars and generic long acting injectables. Xbrane Biopharma AB was founded in 2008 and is headquartered in Solna, Sweden. Xbrane Biopharma operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 35 people.

Xbrane Biopharma Stock Technical Analysis

Xbrane Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Xbrane Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Xbrane Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Diagnostics Now

   

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Module

Xbrane Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Xbrane Biopharma's price direction in advance. Along with the technical and fundamental analysis of Xbrane Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Xbrane to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Xbrane Stock analysis

When running Xbrane Biopharma's price analysis, check to measure Xbrane Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xbrane Biopharma is operating at the current time. Most of Xbrane Biopharma's value examination focuses on studying past and present price action to predict the probability of Xbrane Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xbrane Biopharma's price. Additionally, you may evaluate how the addition of Xbrane Biopharma to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format